Molecular mechanisms that govern infection and antifungal resistance in Mucorales
- PMID: 38445820
- PMCID: PMC10966947
- DOI: 10.1128/mmbr.00188-22
Molecular mechanisms that govern infection and antifungal resistance in Mucorales
Abstract
SUMMARYThe World Health Organization has established a fungal priority pathogens list that includes species critical or highly important to human health. Among them is the order Mucorales, a fungal group comprising at least 39 species responsible for the life-threatening infection known as mucormycosis. Despite the continuous rise in cases and the poor prognosis due to innate resistance to most antifungal drugs used in the clinic, Mucorales has received limited attention, partly because of the difficulties in performing genetic manipulations. The COVID-19 pandemic has further escalated cases, with some patients experiencing the COVID-19-associated mucormycosis, highlighting the urgent need to increase knowledge about these fungi. This review addresses significant challenges in treating the disease, including delayed and poor diagnosis, the lack of accurate global incidence estimation, and the limited treatment options. Furthermore, it focuses on the most recent discoveries regarding the mechanisms and genes involved in the development of the disease, antifungal resistance, and the host defense response. Substantial advancements have been made in identifying key fungal genes responsible for invasion and tissue damage, host receptors exploited by the fungus to invade tissues, and mechanisms of antifungal resistance. This knowledge is expected to pave the way for the development of new antifungals to combat mucormycosis. In addition, we anticipate significant progress in characterizing Mucorales biology, particularly the mechanisms involved in pathogenesis and antifungal resistance, with the possibilities offered by CRISPR-Cas9 technology for genetic manipulation of the previously intractable Mucorales species.
Keywords: CotH; Mucor; RNAi; Rhizopus; dimorphism; genome duplication; host responses; invasins; iron uptake; mucoricin.
Conflict of interest statement
The authors declare no conflict of interest.
Figures






Similar articles
-
Recent Advances and Future Directions in the Understanding of Mucormycosis.Front Cell Infect Microbiol. 2022 Feb 24;12:850581. doi: 10.3389/fcimb.2022.850581. eCollection 2022. Front Cell Infect Microbiol. 2022. PMID: 35281441 Free PMC article. Review.
-
Genetic Manipulation in Mucorales and New Developments to Study Mucormycosis.Int J Mol Sci. 2022 Mar 22;23(7):3454. doi: 10.3390/ijms23073454. Int J Mol Sci. 2022. PMID: 35408814 Free PMC article. Review.
-
cotH Genes Are Necessary for Normal Spore Formation and Virulence in Mucor lusitanicus.mBio. 2023 Feb 28;14(1):e0338622. doi: 10.1128/mbio.03386-22. Epub 2023 Jan 10. mBio. 2023. PMID: 36625576 Free PMC article.
-
Genes, Pathways, and Mechanisms Involved in the Virulence of Mucorales.Genes (Basel). 2020 Mar 16;11(3):317. doi: 10.3390/genes11030317. Genes (Basel). 2020. PMID: 32188171 Free PMC article. Review.
-
Mucormycosis in 2023: an update on pathogenesis and management.Front Cell Infect Microbiol. 2023 Sep 21;13:1254919. doi: 10.3389/fcimb.2023.1254919. eCollection 2023. Front Cell Infect Microbiol. 2023. PMID: 37808914 Free PMC article. Review.
Cited by
-
Epimutations driven by RNAi or heterochromatin evoke antifungal drug resistance in human fungal pathogens.bioRxiv [Preprint]. 2025 Jul 11:2025.06.17.660219. doi: 10.1101/2025.06.17.660219. bioRxiv. 2025. PMID: 40631117 Free PMC article. Preprint.
-
Symmetric adenine methylation is an essential DNA modification in the early-diverging fungus Rhizopus microsporus.Nat Commun. 2025 Apr 24;16(1):3843. doi: 10.1038/s41467-025-59170-x. Nat Commun. 2025. PMID: 40268918 Free PMC article.
-
Molecular architecture of chitin and chitosan-dominated cell walls in zygomycetous fungal pathogens by solid-state NMR.Nat Commun. 2024 Sep 27;15(1):8295. doi: 10.1038/s41467-024-52759-8. Nat Commun. 2024. PMID: 39333566 Free PMC article.
-
The Contribution of Human Antimicrobial Peptides to Fungi.Int J Mol Sci. 2025 Mar 11;26(6):2494. doi: 10.3390/ijms26062494. Int J Mol Sci. 2025. PMID: 40141139 Free PMC article. Review.
-
Editorial: Advancements in the understanding of Mucorales biology and the management of mucormycosis.Front Cell Infect Microbiol. 2024 May 21;14:1427252. doi: 10.3389/fcimb.2024.1427252. eCollection 2024. Front Cell Infect Microbiol. 2024. PMID: 38836052 Free PMC article. No abstract available.
References
-
- Cornely OA, Alastruey-Izquierdo A, Arenz D, Chen SCA, Dannaoui E, Hochhegger B, Hoenigl M, Jensen HE, Lagrou K, Lewis RE, et al. . 2019. Global guideline for the diagnosis and management of mucormycosis: an initiative of the European confederation of medical mycology in cooperation with the mycoses study group education and research consortium. Lancet Infect Dis 19:e405–e421. doi:10.1016/S1473-3099(19)30312-3 - DOI - PMC - PubMed
-
- WHO fungal priority pathogens list to guide research, development and public health action. World Health Organization (WHO). Available from: https://www.who.int/publications/ i/item/9789240060241
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources